Novartis will add a new North Carolina facility for active pharmaceutical ingredient (API) manufacturing for solid dosage ...
Novartis announces a new API facility in Morrisville, NC, as part of its $23bn US manufacturing expansion, boosting biopharma ...
Novartis has finalized its $23 billion U.S. manufacturing and R&D expansion with plans for a new active pharmaceutical ingredient facility in Morrisville, North Carolina. The 56,200-square-foot site ...
Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...
Supriya Lifescience’s Maharashtra API facility receives US FDA EIR with VAI classification: Our Bureau, Mumbai Wednesday, April 22, 2026, 15:45 Hrs [IST] Supriya Lifescience Lim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results